Skip to main content
Fig. 2 | Malaria Journal

Fig. 2

From: In vitro and in vivo anti-malarial activity of novel harmine-analog heat shock protein 90 inhibitors: a possible partner for artemisinin

Fig. 2

Normalized dose–response curve for the competitive binding assay. Binding of (a) 17A and (b) 21A to the ATP binding domain of PfHsp90 was assessed using the bis-ANS competitive binding assay. Reduction in the fluorescence of bis-ANS was measured using a spectrophotometer. The average IC50 values were calculated from three experiments using Graphpad Prism 6. The mean fluorescence and standard error of the mean (SEM) of duplicate wells is shown. Each graph is a representative of three independent experiments

Back to article page